The Future of Drug Safety Promoting and Protecting the Health of the Public (2007) / Chapter Skim
Currently Skimming:
Appendix F Committee Biographies
Appendix F Committee Biographies
Pages 309-318
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 309... ...
Appendix F Committee Biographies COMMITTEE ON THE ASSESSMENT OF THE US DRUG SAFETY SYSTEM Sheila Burke (Chair) , MPA, RN, is deputy secretary and chief operating officer of the Smithsonian Institution.
|
From page 310... ...
0 THE FUTURE OF DRUG SAFETY tor of the Institute for Health Policy at Massachusetts General Hospital and Partners HealthCare System.
|
From page 311... ...
APPENDIX F Drug Administration law, biotechnology law, bioethics, and reproductive rights. In addition, she has served on the UW Hospital clinical-ethics committee, the UW institutional review board for the protection of human subjects in medical research, and the UW Bioethics Advisory Committee.
|
From page 312... ...
Ellenberg was director of the Office of Biostatistics and Epidemiology at the Center for Biologics Evaluation and Research of the Food and Drug Administration (FDA) , chief of the Biostatistics Research Branch in the Division of AIDS of the National Institute of Allergy and Infectious Diseases, and mathematical statistician in the Biometrics Research Branch of the Cancer Therapy Evaluation Program at the National Cancer Institute.
|
From page 313... ...
Dr. Hripcsak was a elected fellow of the American College of Medical Informatics in 1995 and served on the Board of Directors of the American Medical Informatics Association (AMIA)
|
From page 314... ...
Dr. Meltzer's research interests include the theoretical foundations of medical cost-effectiveness analysis, the effects of medical specialization and prospective payment systems on the cost and quality of care, and the effects of Food and Drug Administration regulation on innovation in the pharmaceutical industry.
|
From page 315... ...
Dr. Olson has expertise on Food and Drug Administration (FDA)
|
From page 316... ...
THE FUTURE OF DRUG SAFETY and the Women's Health Initiative. He is the chair of the NIH Cardiovascular Disease and Sleep Epidemiology Study Section and chair of the Group Health Research Committee.
|
From page 317... ...
He was the 1990 American College of Preventive Medicine/Burroughs Wellcome Scholar in Pharmacoepidemiology. The American Association of Pharmaceutical Research Scientists awarded Dr.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.